The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
Open accessAbstract
BACKGROUND: Despite current treatments, patients who have acute coronary syndromes without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy and safety of the antiplatelet agent clopidogrel when given with aspirin in such patients. METHODS: We randomly assigned 12,562 patients who had presented within 24 hours after the onset of symptoms to receive clopidogrel (300 mg immediately, followed by 75 mg once daily) (6259 patients) or placebo (6303 patients) in addition to aspirin for 3 to 12 months. RESULTS: The first primary outcome--a composite of death from cardiovascular causes, nonfatal myocardial infarction, or stroke--occurred in 9.3 percent of the patients in the clopidogrel group and 11.4 percent of the patients in the placebo group (relative risk with clopidogrel as compared with placebo, 0.80; 95 percent confidence interval, 0.72 to 0.90; P<0.001). The second primary outcome--the first primary outcome or refractory ischemia--occurred in 16.5 percent of the patients in the clopidogrel group and 18.8 percent of the patients in the placebo group (relative risk, 0.86; 95 percent confidence interval, 0.79 to 0.94; P<0.001). The percentages of patients with in-hospital refractory or severe ischemia, heart failure, and revascularization procedures were also significantly lower with clopidogrel. There were significantly more patients with major bleeding in the clopidogrel group than in the placebo group (3.7 percent vs. 2.7 percent; relative risk, 1.38; P=0.001), but there were not significantly more patients with episodes of life-threatening bleeding (2.2 percent [corrected] vs. 1.8 percent; P=0.13) or hemorrhagic strokes (0.1 percent vs. 0.1 percent). CONCLUSIONS: The antiplatelet agent clopidogrel has beneficial effects in patients with acute coronary syndromes without ST-segment elevation. However, the risk of major bleeding is increased among patients treated with clopidogrel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and from 6.4% to 4.5% (P ¼ 0.03) over a period of 8 months in NSTEMI patients [Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE)].505”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [505]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Self-citation(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
The GUSTO-I Investigators (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390704 · Cited by 1,431
Self-citationThe Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382102 · Cited by 1,330
Self-citationRao, A. K., Pratt, C. M., Berke, A. D., Jaffe, A. S., Ockene, I. S., SCHREIBER, T. L., Bell, W. R., Knatterud, G. L., ROBERTSON, T. L., & Terrin, M. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90158-1 · Cited by 979
Low-molecular-weight heparin during instability in coronary artery disease
Fragmin during Instability in Coronary Artery Disease (FRISC) study group (1996) · The Lancet · doi:10.1016/s0140-6736(96)91270-2 · Cited by 683
Wallentin, L. C., Swahn, E., Kontny, F. P., Husted, S., Lagerqvist, B., Ståhle, E., Jd, N., Dellborg, M., Geiran, O. R., Grande, P., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)07350-x · Cited by 405
Increased Mortality With Oral Platelet Glycoprotein IIb/IIIa Antagonists
Chew, D. P., Bhatt, D. L., Sapp, S. K., & Topol, E. J. (2001) · Circulation · doi:10.1161/01.cir.103.2.201 · Cited by 359
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,007
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Gersh, B. J. (2010) · Yearbook of Cardiology · doi:10.1016/s0145-4145(09)79737-0 · Cited by 91
Antiplatelet effects and pharmacodynamics of clopidogrel in cats
Hogan, D. F., Andrews, D. A., Green, H. W., Talbott, K. K., Ward, M. P., & Calloway, B. M. (2004) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2004.225.1406 · Cited by 91
Cautionary Tales in the Interpretation of Clinical Studies Involving Older Persons
Scott, I. A., & Guyatt, G. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.18 · Cited by 91
Cuisset, T., Frère, C., Quilici, J., Morange, P., Saut, N., Lambert, M., Camoin‐Jau, L., Juhan-Vague, I., Bonnet, J., & Alessi, M. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.01.012 · Cited by 91
Combined antiplatelet and anticoagulant therapy: clinical benefits and risks
Eikelboom, J. W., & Hirsh, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02499.x · Cited by 91
Management of Patients Undergoing Percutaneous Coronary Revascularization
Levine, G. N., Kern, M. J., Berger, P. B., Brown, D., Klein, L. W., Kereiakes, D. J., Sanborn, T. A., & Jacobs, A. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00012 · Cited by 91
Angiolillo, D. J., Goodman, S. G., Bhatt, D. L., Eikelboom, J. W., Price, M. J., Moliterno, D. J., Cannon, C. P., Tanguay, J., Granger, C. B., Mauri, L., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004395 · Cited by 90
Farooqi, M. A., Gerstein, H. C., Yusuf, S., & Leong, D. P. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014686 · Cited by 93
Age, risk-benefit trade-offs, and the projected effects of evidence-based therapies
Alter, D. A., Manuel, D. G., Gunraj, N., Anderson, G., Naylor, C. D., & Laupacis, A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.039 · Cited by 90
Pharmacogenomics of clopidogrel: Evidence and perspectives
Yin, T., & Miyata, T. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.04.010 · Cited by 91
Amin, A. P., Bachuwar, A., Reid, K. J., Chhatriwalla, A. K., Salisbury, A. C., Yeh, R. W., Kosiborod, M., Wang, T. Y., Alexander, K. P., GOSCH, K. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.044 · Cited by 89
Douketis, J. D., Arneklev, K., Goldhaber, S. Z., Spandorfer, J. M., Halperin, F. A., & Horrow, J. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.8.853 · Cited by 89
A Critical Appraisal of Aspirin in Secondary Prevention
Gargiulo, G., Windecker, S., Vranckx, P., Gibson, C. M., Mehran, R., & Valgimigli, M. (2016) · Circulation · doi:10.1161/circulationaha.116.023952 · Cited by 93
Lip, G. Y. H., & Karpha, M. (2006) · CHEST Journal · doi:10.1378/chest.130.6.1823 · Cited by 89
Management and Prevention of Saphenous Vein Graft Failure: A Review
McKavanagh, P., Yanagawa, B., Zawadowski, G. M., & Cheema, A. N. (2017) · Cardiology and Therapy · doi:10.1007/s40119-017-0094-6 · Cited by 90
Wang, T. Y., Kaltenbach, L. A., Cannon, C. P., Fonarow, G. C., Choudhry, N. K., Henry, T. D., Cohen, D. J., Bhandary, D., Khan, N. D., Anstrom, K. J., et al. (2019) · JAMA · doi:10.1001/jama.2018.19791 · Cited by 87
Platelet P2 receptors: old and new targets for antithrombotic drugs
Cattaneo, M. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.1.45 · Cited by 88
Economic burden of illness of acute coronary syndromes: medical and productivity costs
Zhao, Z., & Winget, M. (2011) · BMC Health Services Research · doi:10.1186/1472-6963-11-35 · Cited by 88
Left anterior descending coronary endarterectomy: Early and late results in 196 consecutive patients
Byrne, J. G., Karavas, A. N., Gudbjartson, T., Leacche, M., Rawn, J. D., Couper, G. S., Rizzo, R. J., Cohn, L. H., & Aranki, S. F. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.03.046 · Cited by 88
Giugliano, R. P., Newby, L. K., Harrington, R. A., Gibson, C. M., de Werf, F. V., Armstrong, P. W., Montalescot, G., Gilbert, J., Strony, J. T., Califf, R. M., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.03.029 · Cited by 88
Casado-Arroyo, R., Polo-Tomás, M., Roncales, M. P., Scheiman, J. M., & Lanas, Á. (2012) · Heart · doi:10.1136/heartjnl-2012-301632 · Cited by 87
Sousa‐Uva, M., Storey, R. F., Huber, K., Falk, V., Leite-Moreira, A. F., Amour, J., Al‐Attar, N., Ascione, R., Taggart, D. P., Collet, J. ‐., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu158 · Cited by 86
Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy
Baber, U., Zafar, M. U., Dangas, G., Escolar, G., Angiolillo, D. J., Sharma, S. K., Kini, A. S., Sartori, S., Joyce, L., Vogel, B., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.056 · Cited by 91
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., Cherney, D. Z. I., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155931 · Cited by 99
Cooke, G. E., Liu-Stratton, Y., Ferketich, A. K., Moeschberger, M. L., Frid, D. J., Magorien, R. D., Bray, P. F., Binkley, P. F., & Goldschmidt‐Clermont, P. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.034 · Cited by 87
Risk factors for gastrointestinal bleeding associated with low-dose aspirin
Valkhoff, V. E., Sturkenboom, M., & Kuipers, E. J. (2012) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2012.01.011 · Cited by 87
Bescós, L. L., Borau, F. A., Lidón, R. M., Cequier, A. R., Bueno, H., Alonso, J. J., Canella, I. C., de Loma-Osorio, A. F., Fernández, J. B., Masiá Martorell, R., et al. (2002) · Revista Española de Cardiología · doi:10.1016/s0300-8932(02)76671-2 · Cited by 87
Fitchett, D., Eikelboom, J., Fremes, S., Mazer, D., Singh, S. K., Bittira, B., Brister, S., Graham, J., Gupta, M., Karkouti, K., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70527-6 · Cited by 88
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 92
Li, Y., Sun, K., Ye, G., Liang, Y., Pan, H., Wang, G., Zhao, Y., Pan, J., Zhang, J., & Fang, J. (2015) · Journal of Endodontics · doi:10.1016/j.joen.2014.10.020 · Cited by 91
Sørensen, R., Abildstrom, S. Z., Hansen, P. R., Hvelplund, A., Andersson, C., Charlot, M. G., Fosbøl, E. L., Køber, L., Madsen, J. K., Gislason, G., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.069 · Cited by 86
Abbas, A. E., Brodie, B. R., Dixon, S. R., Marsalese, D. L., Brewington, S. D., O’Neill, W. W., Grines, L. L., & Grines, C. L. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.038 · Cited by 86
Pickard, A. S., Becker, R. C., Schumock, G. T., & Frye, C. B. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.3.376 · Cited by 86
Jones, L., Griffin, S. C., Palmer, S., Main, C., Orton, V., Sculpher, M. J., Sudlow, C. L. M., Henderson, R., Hawkins, N., & Riemsma, R. P. (2004) · Health Technology Assessment · doi:10.3310/hta8380 · Cited by 86
Platelet function testing and risk of bleeding complications
Ferreiro, J. L., Sibbing, D., & Angiolillo, D. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-11-0799 · Cited by 104
Crawshaw, J., Auyeung, V., Norton, S., & Weinman, J. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.09.003 · Cited by 97
Capodanno, D., Dharmashankar, K., & Angiolillo, D. J. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.172 · Cited by 86
Harmsze, A. M., van Werkum, J. W., Hackeng, C. M., Ruven, H. J. T., Kelder, J. C., Bouman, H. J., Breet, N. J., ten Berg, J. M., Klungel, O. H., de Boer, A., et al. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834ff6e3 · Cited by 85
Plosker, G. L., & Lyseng-Williamson, K. A. (2007) · Drugs · doi:10.2165/00003495-200767040-00013 · Cited by 85
Perioperative handling of patients on antiplatelet therapy with need for surgery
Minno, M. N. D. D., Prisco, D., Ruocco, A. L., Mastronardi, P., Massa, S., & Minno, G. D. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0265-0 · Cited by 86
Boden, W. E., O’Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M. L., Dada, M. R., Casperson, P. R., Harris, C. L., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.082 · Cited by 85
Long-Term Results After the Glycoprotein IIb/IIIa Inhibitor Abciximab in Unstable Angina
Ottervanger, J. P., Armstrong, P. W., Barnathan, E. S., Boersma, E. H., Cooper, J. S., Ohman, E. M., James, S. K., Topol, E. J., Wallentin, L. C., & Simoons, M. L. (2003) · Circulation · doi:10.1161/01.cir.0000046487.06811.5e · Cited by 85
Rimoldi, S. F., yuzefpolskaya, M., Allemann, Y., & Messerli, F. H. (2009) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.10.002 · Cited by 89
Utility of inflammatory markers in the management of coronary artery disease
Rosenson, R. S., & Köenig, W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00504-6 · Cited by 85
Jacob, S., Dunn, B. L., Qureshi, Z. P., Bandarenko, N., Kwaan, H. C., Pandey, D. K., McKoy, J. M., Barnato, S. E., Winters, J. L., Cursio, J., et al. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1328894 · Cited by 84
Singh, S. M., Micieli, A., & Wijeysundera, H. C. (2013) · Circulation · doi:10.1161/circulationaha.112.000920 · Cited by 84
Cardoso, R. N., Benjo, A. M., DiNicolantonio, J. J., García, D., Macedo, F., El‐Hayek, G. E., Nadkarni, G. N., Gili, S., Iannaccone, M., Konstantinidis, I., et al. (2015) · Open Heart · doi:10.1136/openhrt-2015-000248 · Cited by 84
Wrishko, R. E., Ernest, C. S., Small, D. S., Li, Y. G., Weerakkody, G. J., Riesmeyer, J., Macias, W. L., Rohatagi, S., Salazar, D. E., Antman, E. M., et al. (2009) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009337942 · Cited by 84
Chronic stable coronary artery disease: drugs vs. revascularization
Simoons, M. L., & Windecker, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp605 · Cited by 85
Cuisset, T., Frère, C., Quilici, J., Gaborit, B., Bali, L., Poyet, R., Faille, D., Morange, P., Alessi, M., & Bonnet, J. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.02.013 · Cited by 84
Gao, C., Ren, C., Li, D., & Li, L. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.04.024 · Cited by 84
Pharmacotherapy in Chronic Kidney Disease Patients Presenting With Acute Coronary Syndrome
Washam, J. B., Herzog, C. A., Beitelshees, A. L., Cohen, M. G., Henry, T. D., Kapur, N. K., Mega, J. L., Menon, V., Page, R. L., II, & Newby, L. K. (2015) · Circulation · doi:10.1161/cir.0000000000000183 · Cited by 85
Therapeutic options for patients with chronic myocardial ischaemia
Serruys, P. W. J. C. (2004) · European Heart Journal Supplements · doi:10.1016/j.ehjsup.2004.06.005 · Cited by 84
Magnani, G., Storey, R. F., Steg, P. G., Bhatt, D. L., Cohen, M. C., Kuder, J., Im, K., Aylward, P. E., Ardissino, D., Isaza, D., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv482 · Cited by 84
Antiplatelet therapy: new pharmacological agents and changing paradigms
Capodanno, D., Ferreiro, J. L., & Angiolillo, D. J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12219 · Cited by 85
Maltais, S., Perrault, L. P., & Do, Q.-B. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2008.03.052 · Cited by 83
Azar, R. R., Kassab, R., Zoghbi, A., Aboujaoudé, S., El-Osta, H. E., Ghorra, P., Germanos, M., & Salamé, E. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.10.021 · Cited by 83
The Role of Antiplatelet Therapy in Carotid Stenting for Ischemic Stroke Prevention
Chaturvedi, S., & Yadav, J. S. (2006) · Stroke · doi:10.1161/01.str.0000221298.43117.be · Cited by 83
Verma, S., Goodman, S. G., Mehta, S. R., Latter, D. A., Ruel, M., Gupta, M., Yanagawa, B., Al-Omran, M. A., Gupta, N., Teoh, H., et al. (2015) · BMC Surgery · doi:10.1186/s12893-015-0096-z · Cited by 85
Role of Platelet Activation and Oxidative Stress in the Evolution of Myocardial Infarction
Eduardo Fuentes, Q., Moore‐Carrasco, R., Paes, A. M. D. A., & Trostchansky, A. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419861437 · Cited by 81
Platelet function tests in clinical cardiology: unfulfilled expectations.
Gorog, D. A., & Fuster, V. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.080 · Cited by 83
Liu, O., Jia, L., Liu, X., Wang, Y., Wang, X., Qin, Y., Du, J., & Zhang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051707 · Cited by 82
Husted, S., James, S. K., Bach, R. G., Becker, R. C., Budaj, A., Heras, M., Himmelmänn, A., Horrow, J. C., Katus, H. A., Lassila, R., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu075 · Cited by 82
Chalmers, J. P., Todd, A. L., Chapman, N., Beilin, L., Davis, S. M., Donnan, G. A., Frommer, M. S., Huxley, R., Lenfant, C. J. M., MacMahon, S. W., et al. (2003) · PubMed · doi:10.1097/01.hjh.0000052490.18130.95 · Cited by 82
Optimal Medical Management of Peripheral Arterial Disease
Rice, T., & Lumsden, A. (2006) · Vascular and Endovascular Surgery · doi:10.1177/1538574406291835 · Cited by 88
Clopidogrel in Infants with Systemic-to-Pulmonary-Artery Shunts
WESSEL, D. L., Berger, F. F., Li, J. S., Dähnert, I., Rakhit, A., Fontecave, S., & Newburger, J. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1114588 · Cited by 81
Cuisset, T., Frère, C., Quilici, J., Morange, P., Camoin‐Jau, L., Bali, L., Lambert, M., Juhan-Vague, I., Alessi, M., & Bonnet, J. (2008) · Thrombosis Research · doi:10.1016/j.thromres.2008.04.003 · Cited by 81
Therapeutic approaches in arterial thrombosis
Phillips, D. R., Conley, P. B., Sinha, U., & André, P. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01418.x · Cited by 81
Zimmermann, N., Gams, E., & Hohlfeld, T. (2008) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2008.03.023 · Cited by 85
Evolution of Coronary Stent Technology and Implications for Duration of Dual Antiplatelet Therapy
Moon, J. Y., Franchi, F., Rollini, F., & Angiolillo, D. J. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.004 · Cited by 81
Bleeding and management of bleeding
Eikelboom, J. W., & Hirsh, J. (2006) · European Heart Journal Supplements · doi:10.1093/eurheartj/sul054 · Cited by 81
Komócsi, A., Vorobcsuk, A., Kehl, D., & Aradi, D. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.4026 · Cited by 79
Leonardi, S., Rao, S. V., Harrington, R. A., Bhatt, D. L., Gibson, C. M., Roe, M. T., Kochman, J., Huber, K., Zeymer, U., Madan, M., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.04.008 · Cited by 80
Warnholtz, A., Ostad, M. A., Velich, N., Trautmann, C., Schinzel, R., Walter, U., & Münzel, T. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.12.009 · Cited by 80
Leonardi, S., Mahaffey, K. W., White, H. D., Gibson, C. M., Stone, G. W., Steg, P. G., Hamm, C. W., Price, M. J., Todd, M., Dietrich, M., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.02.018 · Cited by 79
Ray, J. G., Deniz, S., Olivieri, A., Pollex, E. K., Vermeulen, M. J., Alexander, K. S., Cain, D. J., Cybulsky, I. J., & Hamielec, C. M. (2003) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-3-3 · Cited by 80
Werns, S. W. (2012) · Yearbook of Critical Care Medicine · doi:10.1016/j.yccm.2012.01.039 · Cited by 80
Perioperative antiplatelet therapy.
Chassot, P.-G., Marcucci, C., Delabays, A., & Spahn, D. R. (2010) · PubMed · Cited by 80
How to Manage the Renal Patient with Coronary Heart Disease
Herzog, C. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000087640.94746.47 · Cited by 80
Kaikita, K., Hosokawa, K., Dahlen, J. R., & Tsujita, K. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-1693411 · Cited by 83
Aronow, H. D., Steinhubl, S. R., Brennan, D. M., Berger, P. B., & Topol, E. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.09.011 · Cited by 79
Impact of race and gender on antithrombotic therapy
Capodanno, D., & Angiolillo, D. J. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-04-0232 · Cited by 79
Some issues with composite endpoints in clinical trials
Chi, G. Y. H. (2005) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2005.00370.x · Cited by 79
Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery.
Blasco-Colmenares, E., Perl, T., Guallar, E., Baumgartner, W., Conte, J., Alejo, D., Pastor-Barriuso, R., Sharrett, A., & Faraday, N. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.42 · Cited by 73
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 89
Schamroth, C. (2012) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2012-017 · Cited by 78
Recomendaciones preventivas cardiovasculares
Galán, Á. M. M., Cuixart, C. B., Álvarez, F. V., Pérez, J. N., Lobos-Bejarano, J. M., Sánchez-Pinilla, R. O., Rioboó, E. M., Banegas, J. R. B., Orozco‐Beltrán, D., & Gil-Guillén, V. F. (2012) · Atención Primaria · doi:10.1016/s0212-6567(12)70010-0 · Cited by 78
Nutrition, Supplements, and Vitamins in Platelet Function and Bleeding
Violi, F., Pignatelli, P., & Basili, S. (2010) · Circulation · doi:10.1161/circulationaha.109.880211 · Cited by 78
Oylumlu, M., Yıldız, A., Oylumlu, M., Yüksel, M., Polat, N., Bilik, M. Z., Akyüz, A., Aydın, M., Acet, H., & Soydinç, S. (2014) · The Anatolian Journal of Cardiology · doi:10.5152/akd.2014.5366 · Cited by 78
Bunchorntavakul, C., & Reddy, K. R. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.009 · Cited by 81
Hoenig, M. R., Aroney, C. N., & Scott, I. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004815.pub3 · Cited by 78
Koul, S. M., Smith, J. G., Scherstén, F., James, S. K., Lagerqvist, B., & Erlinge, D. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr202 · Cited by 77
Simonsson, M., Wallentin, L. C., Alfredsson, J., Erlinge, D., Ängerud, K. H., Hofmann, R., Kellerth, T., Lindhagen, L., Ravn‐Fischer, A., Szummer, K. E., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz593 · Cited by 77
Patient blood management during cardiac surgery: Do we have enough evidence for clinical practice?
Ranucci, M., Aronson, S., Dietrich, W., Dyke, C., Hofmann, A., Karkouti, K., Levi, M. M., Murphy, G. J., Sellke, F. W., Shore-Lesserson, L. J., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.04.007 · Cited by 76
A New Paradigm for Plaque Stabilization
Ambrose, J. A., & Martinez, E. E. (2002) · Circulation · doi:10.1161/01.cir.0000012528.89469.8e · Cited by 77
Cannon, C. P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02606-1 · Cited by 77
Nijenhuis, V. J., Bennaghmouch, N., Hassell, M. E. C. J., Baan, J., van Kuijk, J. P., Agostoni, P., Hof, A. W. J. V. ’., Kievit, P. C., Veenstra, L. F., van der Harst, P., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.11.008 · Cited by 76
Cuisset, T., Grosdidier, C., Loundou, A., Quilici, J., Loosveld, M., Camoin‐Jau, L., Pankert, M., Beguin, S., Lambert, M., Morange, P., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.04.009 · Cited by 76
Tailor-made amino acids in the design of small-molecule blockbuster drugs
Han, J., Konno, H., Sato, T., Soloshonok, V. A., & Izawa, K. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113448 · Cited by 76
Bularga, A., Hung, J., Daghem, M., Stewart, S., Taggart, C., Wereski, R., Singh, T., Meah, M. N., Fujisawa, T., Ferry, A. V., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.058542 · Cited by 76
Metadata
- Authors
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
- Affiliations
- Hamilton General Hospital (CA)
- Corresponding author
- The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-08-16
- Volume
- 345
- Issue
- 7
- Pages
- 494-502
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1553345686
- Cited by
- 6,470
- References
- 16
- Citations by year
- 2026: 63 · 2025: 99 · 2024: 77 · 2023: 110 · 2022: 121 · 2021: 163 · 2020: 168 · 2019: 202 · 2018: 216 · 2017: 229 · 2016: 265 · 2015: 325 · 2014: 319 · 2013: 397 · 2012: 395
- FWCI
- 178.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Repository of the Academy's Library (Library of the Hungarian Academy of Sciences) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- clopidogrel, aspirin, antiplatelet therapy, major bleeding, refractory ischemia, cardiovascular mortality, myocardial infarction, stroke, heart failure, revascularization
- MeSH terms
- Clopidogrel, Acute Disease, Aged, Aspirin, Cardiovascular Diseases, Drug Therapy, Combination, Electrocardiography, Female, Hemorrhage, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Ticlopidine, Myocardial Ischemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
